Status:

COMPLETED

Extracorporeal Shock Wave Therapy in Osteoarthritis

Lead Sponsor:

King Saud University

Conditions:

Osteoarthritis, Knee

Eligibility:

All Genders

45-60 years

Phase:

NA

Brief Summary

The present study has examined the effectiveness of extracorporeal shock wave therapy along with conventional physical therapy on functional ability in grade IV knee osteoarthritis. Intervention progr...

Eligibility Criteria

Inclusion

  • Grade IV primary knee Osteoarthritis (OA) diagnosed by an orthopaedic surgeon based on the Kellgren-Lawrence score

Exclusion

  • Secondary knee OA,
  • rheumatoid arthritis,
  • psoriatic arthritis,
  • the presence of any red flags (metastatic growth, thrombophlebitis),
  • neurologic or psychiatric impairments,
  • tissue injuries of the knee joint,
  • previous knee joint replacement or other surgeries in the knee joint,
  • already received ESWT,
  • Intra articular injection
  • unable to walk independently

Key Trial Info

Start Date :

December 6 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 27 2022

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06181955

Start Date

December 6 2021

End Date

April 27 2022

Last Update

December 26 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

King Saud University

Riyadh, Saudi Arabia, 11433